eplex respiratory pathogen (rp) panel (GenMark Diagnostics)
90
Structured Review
GenMark Diagnostics
eplex respiratory pathogen (rp) panel
Eplex Respiratory Pathogen (Rp) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex+respiratory+pathogen+(rp)+panel/eplex+respiratory+pathogen+panel/pm37063449-39-11-16
Average 90 stars, based on 1 article reviews
Eplex Respiratory Pathogen (Rp) Panel, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eplex+respiratory+pathogen+(rp)+panel/eplex+respiratory+pathogen+panel/pm37063449-39-11-16
Average 90 stars, based on 1 article reviews
eplex respiratory pathogen (rp) panel - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Virus:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Multiplex Assay:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Luminex:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Bacteria:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Bla VIM Assay:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Clinical Proteomics:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Reverse Transcription Polymerase Chain Reaction:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Amplification:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Quantitative RT-PCR:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Microarray:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: DNA Hybridization:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Hybridization:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: Real-time Polymerase Chain Reaction:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: DNA Amplification:Article Title: Updates on Rapid Diagnostic Tests in Infectious Diseases Article Snippet: There are currently five FDA-cleared multiplex panels for respiratory pathogens: NxTAG Respiratory Pathogen Panel (Luminex Molecular Diagnostics, Toronto, Canada), FilmArray Respiratory Panel (bioMérieux, Marcy l’Etoile, France), Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) (Luminex Molecular Diagnostics, Toronto, Canada), Article Title: Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections. Article Snippet: The GenMark Dx ePlex Respiratory Pathogen Panel (RP) is a multiplexed nucleic acid test for the qualitative detection of common viral and a few bacterial causes of respiratory tract infections.. The ePlex RP has received FDA clearance for nasopharyngeal swab (NPS) specimens collected in viral transport media.. In this study, we evaluated the performance of the ePlex RP panel in comparison to the NxTAG Respiratory Pathogen Panel (NxTAG-RPP) from Luminex in use in our laboratory, not only for NPS but also for bronchoalveolar lavage specimens (BAL). Article Title: An updated roadmap for MERS-CoV research and product development: focus on diagnostics Article Snippet: 98%-100% Article Title: Panels and Syndromic Testing in Clinical Microbiology Article Snippet: Article Title: Nasopharyngeal metabolomics and machine learning approach for the diagnosis of influenza Article Snippet: Respiratory viral testing was performed on the Article Title: Targeted plasma metabolomics combined with machine learning for the diagnosis of severe acute respiratory syndrome virus type 2. Article Snippet: For the latter group, respiratory viral testing was performed on the Article Title: Laboratory Diagnosis of Respiratory Tract Infections in Children – the State of the Art Article Snippet: |
